Cargando…

Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression

BACKGROUND: Type 2 diabetes mellitus (T2DM) is a complex systemic disease, with significant disorders of metabolism. The liver, a central energy metabolic organ, plays a critical role in the development of diabetes. Although gene expression levels are able to be measured via microarray since 1996, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Huarong, Saito, Shigeru, Piao, Guanying, Liu, Zhi-Ping, Wang, Jiguang, Horimoto, Katsuhisa, Chen, Luonan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121116/
https://www.ncbi.nlm.nih.gov/pubmed/21689475
http://dx.doi.org/10.1186/1752-0509-5-S1-S16
_version_ 1782206799595700224
author Zhou, Huarong
Saito, Shigeru
Piao, Guanying
Liu, Zhi-Ping
Wang, Jiguang
Horimoto, Katsuhisa
Chen, Luonan
author_facet Zhou, Huarong
Saito, Shigeru
Piao, Guanying
Liu, Zhi-Ping
Wang, Jiguang
Horimoto, Katsuhisa
Chen, Luonan
author_sort Zhou, Huarong
collection PubMed
description BACKGROUND: Type 2 diabetes mellitus (T2DM) is a complex systemic disease, with significant disorders of metabolism. The liver, a central energy metabolic organ, plays a critical role in the development of diabetes. Although gene expression levels are able to be measured via microarray since 1996, it is difficult to evaluate the contributions of one altered gene expression to a specific disease. One of the reasons is that a whole network picture responsible for a specific phase of diabetes is missing, while a single gene has to be put into a network picture to evaluate its importance. In the aim of identifying significant transcriptional regulatory networks in the liver contributing to diabetes, we have performed comprehensive active regulatory network survey by network screening in 4 weeks (w), 8-12 w, and 18-20 w Goto-Kakizaki (GK) rat liver microarray data. RESULTS: We identify active regulatory networks in GK rat by network screening in the following procedure. First, the regulatory networks are compiled by using the known binary relationships between the transcriptional factors and their regulated genes and the biological classification scheme, and second, the consistency of each regulatory network with the microarray data measured in GK rat is estimated to detect the active networks under the corresponding conditions. The comprehensive survey of the consistency between the networks and the measured data by the network screening approach in the case of non-insulin dependent diabetes in the GK rat reveals: 1. More pathways are active during inter-middle stage diabetes; 2. Inflammation, hypoxia, increased apoptosis, decreased proliferation, and altered metabolism are characteristics and display as early as 4weeks in GK strain; 3. Diabetes progression accompanies insults and compensations; 4. Nuclear receptors work in concert to maintain normal glycemic robustness system. CONCLUSION: Notably this is the first comprehensive network screening study of non-insulin dependent diabetes in the GK rat based on high throughput data of the liver. Several important pathways have been revealed playing critical roles in the diabetes progression. Our findings also implicate that network screening is able to help us understand complex disease such as diabetes, and demonstrate the power of network systems biology approach to elucidate the essential mechanisms which would escape conventional single gene-based analysis.
format Online
Article
Text
id pubmed-3121116
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31211162011-06-23 Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression Zhou, Huarong Saito, Shigeru Piao, Guanying Liu, Zhi-Ping Wang, Jiguang Horimoto, Katsuhisa Chen, Luonan BMC Syst Biol Report BACKGROUND: Type 2 diabetes mellitus (T2DM) is a complex systemic disease, with significant disorders of metabolism. The liver, a central energy metabolic organ, plays a critical role in the development of diabetes. Although gene expression levels are able to be measured via microarray since 1996, it is difficult to evaluate the contributions of one altered gene expression to a specific disease. One of the reasons is that a whole network picture responsible for a specific phase of diabetes is missing, while a single gene has to be put into a network picture to evaluate its importance. In the aim of identifying significant transcriptional regulatory networks in the liver contributing to diabetes, we have performed comprehensive active regulatory network survey by network screening in 4 weeks (w), 8-12 w, and 18-20 w Goto-Kakizaki (GK) rat liver microarray data. RESULTS: We identify active regulatory networks in GK rat by network screening in the following procedure. First, the regulatory networks are compiled by using the known binary relationships between the transcriptional factors and their regulated genes and the biological classification scheme, and second, the consistency of each regulatory network with the microarray data measured in GK rat is estimated to detect the active networks under the corresponding conditions. The comprehensive survey of the consistency between the networks and the measured data by the network screening approach in the case of non-insulin dependent diabetes in the GK rat reveals: 1. More pathways are active during inter-middle stage diabetes; 2. Inflammation, hypoxia, increased apoptosis, decreased proliferation, and altered metabolism are characteristics and display as early as 4weeks in GK strain; 3. Diabetes progression accompanies insults and compensations; 4. Nuclear receptors work in concert to maintain normal glycemic robustness system. CONCLUSION: Notably this is the first comprehensive network screening study of non-insulin dependent diabetes in the GK rat based on high throughput data of the liver. Several important pathways have been revealed playing critical roles in the diabetes progression. Our findings also implicate that network screening is able to help us understand complex disease such as diabetes, and demonstrate the power of network systems biology approach to elucidate the essential mechanisms which would escape conventional single gene-based analysis. BioMed Central 2011-06-20 /pmc/articles/PMC3121116/ /pubmed/21689475 http://dx.doi.org/10.1186/1752-0509-5-S1-S16 Text en Copyright ©2011 Zhou et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Report
Zhou, Huarong
Saito, Shigeru
Piao, Guanying
Liu, Zhi-Ping
Wang, Jiguang
Horimoto, Katsuhisa
Chen, Luonan
Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression
title Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression
title_full Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression
title_fullStr Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression
title_full_unstemmed Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression
title_short Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression
title_sort network screening of goto-kakizaki rat liver microarray data during diabetic progression
topic Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121116/
https://www.ncbi.nlm.nih.gov/pubmed/21689475
http://dx.doi.org/10.1186/1752-0509-5-S1-S16
work_keys_str_mv AT zhouhuarong networkscreeningofgotokakizakiratlivermicroarraydataduringdiabeticprogression
AT saitoshigeru networkscreeningofgotokakizakiratlivermicroarraydataduringdiabeticprogression
AT piaoguanying networkscreeningofgotokakizakiratlivermicroarraydataduringdiabeticprogression
AT liuzhiping networkscreeningofgotokakizakiratlivermicroarraydataduringdiabeticprogression
AT wangjiguang networkscreeningofgotokakizakiratlivermicroarraydataduringdiabeticprogression
AT horimotokatsuhisa networkscreeningofgotokakizakiratlivermicroarraydataduringdiabeticprogression
AT chenluonan networkscreeningofgotokakizakiratlivermicroarraydataduringdiabeticprogression